Capstone Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Buy
20,700
+8,723
+73% +$682K ﹤0.01% 324
2025
Q1
$868K Sell
11,977
-8,217
-41% -$596K ﹤0.01% 350
2024
Q4
$1.49M Sell
20,194
-4,595
-19% -$340K ﹤0.01% 308
2024
Q3
$1.64M Buy
24,789
+21,818
+734% +$1.44M 0.01% 223
2024
Q2
$274K Sell
2,971
-1,696
-36% -$157K ﹤0.01% 788
2024
Q1
$446K Buy
+4,667
New +$446K ﹤0.01% 878
2023
Q4
Sell
-15,743
Closed -$1.09M 1176
2023
Q3
$1.09M Buy
15,743
+15,593
+10,395% +$1.08M ﹤0.01% 376
2023
Q2
$14.2K Buy
150
+141
+1,567% +$13.3K ﹤0.01% 845
2023
Q1
$745 Sell
9
-9,179
-100% -$760K ﹤0.01% 595
2022
Q4
$686K Sell
9,188
-41,513
-82% -$3.1M 0.01% 426
2022
Q3
$4.19M Buy
50,701
+31,568
+165% +$2.61M 0.03% 222
2022
Q2
$1.82M Buy
+19,133
New +$1.82M 0.01% 341
2022
Q1
Hold
0
1020
2021
Q4
Hold
0
896
2021
Q3
Sell
-1,416
Closed -$147K 970
2021
Q2
$147K Sell
1,416
-10,779
-88% -$1.12M ﹤0.01% 522
2021
Q1
$1.02M Buy
+12,195
New +$1.02M ﹤0.01% 236
2020
Q4
Hold
0
640
2020
Q3
Sell
-35,287
Closed -$2.44M 436
2020
Q2
$2.44M Buy
35,287
+3,292
+10% +$228K 0.02% 106
2020
Q1
$2.01M Sell
31,995
-996
-3% -$62.6K 0.03% 113
2019
Q4
$2.57M Buy
32,991
+32,964
+122,089% +$2.56M 0.01% 161
2019
Q3
$2K Sell
27
-126
-82% -$9.33K ﹤0.01% 350
2019
Q2
$9K Buy
153
+6
+4% +$353 ﹤0.01% 432
2019
Q1
$9K Sell
147
-267
-64% -$16.3K ﹤0.01% 360
2018
Q4
$21K Buy
414
+156
+60% +$7.91K ﹤0.01% 373
2018
Q3
$15K Buy
+258
New +$15K ﹤0.01% 438
2017
Q4
Sell
-45,591
Closed -$1.66M 433
2017
Q3
$1.66M Buy
45,591
+5,406
+13% +$197K 0.06% 103
2017
Q2
$1.58M Buy
40,185
+29,619
+280% +$1.17M 0.04% 226
2017
Q1
$331K Buy
+10,566
New +$331K 0.01% 535
2016
Q3
Sell
-97,146
Closed -$3.23M 657
2016
Q2
$3.23M Buy
97,146
+80,976
+501% +$2.69M 0.06% 116
2016
Q1
$475K Sell
16,170
-16,098
-50% -$473K 0.01% 369
2015
Q4
$849K Buy
+32,268
New +$849K 0.02% 178